Cargando…
Fingolimod for multiple sclerosis and emerging indications: appropriate patient selection, safety precautions, and special considerations
Fingolimod (FTY720), an immunotherapeutic drug targeting the sphingosine-1-phosphate receptor, is a widely used medication for relapsing-remitting multiple sclerosis (MS). Apart from the pivotal Phase III trials demonstrating efficacy against placebo and interferon-β-1a once weekly, sufficient clini...
Autores principales: | Ayzenberg, Ilya, Hoepner, Robert, Kleiter, Ingo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4767105/ https://www.ncbi.nlm.nih.gov/pubmed/26929636 http://dx.doi.org/10.2147/TCRM.S65558 |
Ejemplares similares
-
Fingolimod for Irradiation-Induced Neurodegeneration
por: Metzdorf, Judith, et al.
Publicado: (2019) -
Dimethyl fumarate in the management of multiple sclerosis: appropriate patient selection and special considerations
por: Prosperini, Luca, et al.
Publicado: (2016) -
An update on the use of natalizumab in the treatment of multiple sclerosis: appropriate patient selection and special considerations
por: Kornek, Barbara
Publicado: (2015) -
Safety and Efficacy of Fingolimod in Treatment-Naïve Multiple Sclerosis Patients
por: Marriott, James J.
Publicado: (2011) -
Determination of Seminal Concentration of Fingolimod and Fingolimod‐Phosphate in Multiple Sclerosis Patients Receiving Chronic Treatment With Fingolimod
por: David, Olivier J., et al.
Publicado: (2017)